Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ai-Ming Yu

Showing results (101-110 of 139) with videos related to

Pageof 14
Sort By:
Cancers|April 30, 2021
Targeting Feedforward Loops Formed by Nuclear Receptor RORγ and Kinase PBK in mCRPC with Hyperactive AR SignalingXiong Zhang, Zenghong Huang, Junjian Wang, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|November 28, 2008
Protein kinase A modulates Cdc25B activity during meiotic resumption of mouse oocytesYang Zhang, Zhe Zhang, Xiao-Yan Xu, et al.
Acta Pharmaceutica Sinica. B|October 6, 2023
Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancerYixin Chen, Mei-Juan Tu, Fangwei Han, et al.
The Journal of Biological Chemistry|December 10, 2013
Altered expression of small heterodimer partner governs cytochrome P450 (CYP) 2D6 induction during pregnancy in CYP2D6-humanized miceKwi Hye Koh, Xian Pan, Hong-Wu Shen, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 23, 2003
The relative contribution of monoamine oxidase and cytochrome p450 isozymes to the metabolic deamination of the trace amine tryptamineAi-Ming Yu, Camille P Granvil, Robert L Haining, et al.
Biochemical Pharmacology|November 1, 2015
Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growthYong Zhao, Mei-Juan Tu, Yi-Feng Yu, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|January 17, 2015
Effects of nicotinamide N-methyltransferase on PANC-1 cells proliferation, metastatic potential and survival under metabolic stressTao Yu, Yong-Tao Wang, Pan Chen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 25, 2017
Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer CellsPeng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2025
Circadian regulator REV-ERBα is a master regulator of tumor lineage plasticity and an effective therapeutic targetXiong Zhang, Yatian Yang, Hongye Zou, et al.
Acta Pharmaceutica Sinica. B|May 15, 2025
Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitorsXiong Zhang, Yatian Yang, Hongye Zou, et al.
Pageof 14

Showing results (101-110 of 139) with videos related to

Sort By:
Pageof 14
Cancers|April 30, 2021
Targeting Feedforward Loops Formed by Nuclear Receptor RORγ and Kinase PBK in mCRPC with Hyperactive AR SignalingXiong Zhang, Zenghong Huang, Junjian Wang, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|November 28, 2008
Protein kinase A modulates Cdc25B activity during meiotic resumption of mouse oocytesYang Zhang, Zhe Zhang, Xiao-Yan Xu, et al.
Acta Pharmaceutica Sinica. B|October 6, 2023
Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancerYixin Chen, Mei-Juan Tu, Fangwei Han, et al.
The Journal of Biological Chemistry|December 10, 2013
Altered expression of small heterodimer partner governs cytochrome P450 (CYP) 2D6 induction during pregnancy in CYP2D6-humanized miceKwi Hye Koh, Xian Pan, Hong-Wu Shen, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 23, 2003
The relative contribution of monoamine oxidase and cytochrome p450 isozymes to the metabolic deamination of the trace amine tryptamineAi-Ming Yu, Camille P Granvil, Robert L Haining, et al.
Biochemical Pharmacology|November 1, 2015
Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growthYong Zhao, Mei-Juan Tu, Yi-Feng Yu, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|January 17, 2015
Effects of nicotinamide N-methyltransferase on PANC-1 cells proliferation, metastatic potential and survival under metabolic stressTao Yu, Yong-Tao Wang, Pan Chen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 25, 2017
Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer CellsPeng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2025
Circadian regulator REV-ERBα is a master regulator of tumor lineage plasticity and an effective therapeutic targetXiong Zhang, Yatian Yang, Hongye Zou, et al.
Acta Pharmaceutica Sinica. B|May 15, 2025
Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitorsXiong Zhang, Yatian Yang, Hongye Zou, et al.
Pageof 14